Rates of obesity and related metabolic disorders have increased substantially over the past 20 years. However, despite the significant work being done, translation of progress in this area into clinically useful advances has been inadequate. Recognizing this critical gap, the Nutrition Obesity Research Center at Harvard (NORC-H) has continued to evolve through a deliberative process of restructuring, to enable key goals of the Center and larger Nutrition Obesity Community. In this regard, the new Center Leadership, under Dr. Grinspoon, a well recognized expert in human metabolic phenotyping and ectopic adipose tissue, has worked closely with Dr. Allan Walker, the prior Director, in consultation with the EAB to restructure the Center to leverage the strengths of the investigative base, to achieve the goals below. The Center has been successful, as judged by its scientific achievements, with key metrics of success in terms of publications, and grant support. To harness strength of the Research community at Harvard to address extensive questions related to obesity, nutrition and metabolism, the Center has expanded core use to include metabolic phenotyping, translational model development, development of tissue specific cell types from stem cells, and functional imaging for adipose tissue, substrate flux, and higher cortical satiety and hunger pathways organized into 6 specific themes. This work leverages and simultaneously facilitates the work of the numerous faculty members actively engaged in nutrition and obesity research across the Harvard schools of medicine and public health and affiliated hospitals. The NORC-H has enjoyed great success in fostering cross-institutional and cross- disciplinary collaborations between researchers for 2 decades. The NORC-H will continue to develop its highly successful focus on enrichment and promotion of nutrition and obesity related science and utilize a high quality P&F Program to provide pilot funding to advance highly deserving scientists with significant potential. The goals of the Center are to identify and promote a highly productive research base centered around key thematic interests unique to the Center, with potential to translate research findings into clinically useful strategies for human advancement, to make sophisticated phenotyping and model development services available to clinical and translational researchers both within and beyond the Harvard community through novel core services, and to make the knowledge of these advancements available through a robust enrichment, education and outreach program, including via our annual symposium, P&F symposium, website and outreach to other NORCS to ensure that the community benefits maximally from the Center.

Public Health Relevance

The Nutrition Obesity Research Center at Harvard (NORC-H) supports a large base of investigators throughout the Harvard system who are engaged in research in the fields of nutrition and obesity and who have made substantial contributions to these fields. The NORC-H fosters community and collaboration among these researchers and provides critical support to both senior and junior investigators in the form of Core services, Pilot and Feasibility Grants, statistical support, and opportunities to share and disseminate research findings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK040561-21
Application #
9385960
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Evans, Mary
Project Start
1997-09-01
Project End
2022-07-31
Budget Start
2017-08-01
Budget End
2018-07-31
Support Year
21
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Syed, Sana; Iqbal, Najeeha T; Sadiq, Kamran et al. (2018) Serum anti-flagellin and anti-lipopolysaccharide immunoglobulins as predictors of linear growth faltering in Pakistani infants at risk for environmental enteric dysfunction. PLoS One 13:e0193768
Foldyna, Borek; Fourman, Lindsay T; Lu, Michael T et al. (2018) Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr 78:421-428
Xu, He; Lee, Min-Sik; Tsai, Pei-Yun et al. (2018) Ablation of insulin receptor substrates 1 and 2 suppresses Kras-driven lung tumorigenesis. Proc Natl Acad Sci U S A 115:4228-4233
Cheru, Lediya T; Fitch, Kathleen V; Saylor, Charles F et al. (2018) Mild renal impairment is associated with calcified plaque parameters assessed by CT angiography in people living with HIV. AIDS :
Benson, Mark D; Yang, Qiong; Ngo, Debby et al. (2018) Genetic Architecture of the Cardiovascular Risk Proteome. Circulation 137:1158-1172
Jacobson, Sandra W; Carter, R Colin; Molteno, Christopher D et al. (2018) Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Alcohol Clin Exp Res 42:1327-1341
Li, L-J; Rifas-Shiman, S L; Aris, I M et al. (2018) Associations of maternal and cord blood adipokines with offspring adiposity in Project Viva: is there an interaction with child age? Int J Obes (Lond) 42:608-617
Catalano, Onofrio Antonio; Wu, Vincent; Mahmood, Umar et al. (2018) Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease. Am J Nucl Med Mol Imaging 8:62-69
Patel, Dhiren K; Stanford, Fatima Cody (2018) Safety and tolerability of new-generation anti-obesity medications: a narrative review. Postgrad Med 130:173-182
Triant, Virginia A; Perez, Jeremiah; Regan, Susan et al. (2018) Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection. Circulation 137:2203-2214

Showing the most recent 10 out of 1081 publications